<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font20 { font-size : 20; } .font22 { font-size : 22; } .font27 { font-size : 27; } .font28 { font-size : 28; } .font29 { font-size : 29; } .font31 { font-size : 31; }</style>
 <body>
  <p>
   <span class="font31">migraine </span>
   <span class="font29">headache </span>
   <span class="font28">treatment </span>
   <span class="font27">children </span>
   <span class="font22">Headache </span>
   <span class="font20">./j.-...x </span>
   <span class="font18">RCT </span>
   <span class="font18">study </span>
   <span class="font17">childhood </span>
   <span class="font16">{border-style </span>
   <span class="font16">effective </span>
   <span class="font15">acute </span>
   <span class="font15">patients </span>
   <span class="font15">px;} </span>
   <span class="font15">#ffffff;} </span>
   <span class="font15">Cephalalgia </span>
   <span class="font15">Neurol </span>
   <span class="font15">adolescents </span>
   <span class="font15">management </span>
   <span class="font15">placebo </span>
   <span class="font14">Pain </span>
   <span class="font14">clinical </span>
   <span class="font14">placebo-controlled </span>
   <span class="font14">studies </span>
   <span class="font14">drug </span>
   <span class="font14">headaches </span>
   <span class="font14">paediatric </span>
   <span class="font14">pediatric </span>
   <span class="font14">prophylaxis </span>
   <span class="font13">Sumatriptan </span>
   <span class="font13">medications </span>
   <span class="font13">mg/kg </span>
   <span class="font13">controlled </span>
   <span class="font13">data </span>
   <span class="font13">drugs </span>
   <span class="font13">efficacy </span>
   <span class="font13">medication </span>
   <span class="font13">sumatriptan </span>
   <span class="font13">TTH </span>
   <span class="font13">Winner </span>
   <span class="font13">attacks </span>
   <span class="font13">cluster </span>
   <span class="font13">prophylactic </span>
   <span class="font13">randomized </span>
   <span class="font13">trial </span>
   <span class="font12">Neurology </span>
   <span class="font12">Rizatriptan </span>
   <span class="font12">double-blind, </span>
   <span class="font12">headache. </span>
   <span class="font12">headache: </span>
   <span class="font12">non-pharmacological </span>
   <span class="font12">pain </span>
   <span class="font12">Cluster </span>
   <span class="font12">Guidetti </span>
   <span class="font12">Lewis </span>
   <span class="font12">Prophylactic </span>
   <span class="font12">age </span>
   <span class="font12">biofeedback </span>
   <span class="font12">common </span>
   <span class="font12">nasal </span>
   <span class="font12">px; </span>
   <span class="font12">relief </span>
   <span class="font12">response </span>
   <span class="font12">symptomatic </span>
   <span class="font12">therapeutic </span>
   <span class="font12">use </span>
   <span class="font12">{font-family </span>
   <span class="font12">&amp;lt; </span>
   <span class="font12">(HA </span>
   <span class="font12">./s--- </span>
   <span class="font12">Child </span>
   <span class="font12">Flunarizine </span>
   <span class="font12">Hershey </span>
   <span class="font12">Linder </span>
   <span class="font12">adolescent </span>
   <span class="font12">chronic </span>
   <span class="font12">effects </span>
   <span class="font12">font-size </span>
   <span class="font12">oral </span>
   <span class="font12">randomized, </span>
   <span class="font12">tension-type </span>
   <span class="font12">therapy </span>
   <span class="font12">treatment. </span>
   <span class="font12">treatments </span>
   <span class="font12">trials </span>
   <span class="font12">versus </span>
   <span class="font11">&amp;lt;. </span>
   <span class="font11">Hamalainen </span>
   <span class="font11">Level </span>
   <span class="font11">Pediatr </span>
   <span class="font11">Propranolol </span>
   <span class="font11">Topiramate </span>
   <span class="font11">appropriate </span>
   <span class="font11">care </span>
   <span class="font11">daily </span>
   <span class="font11">diagnosis </span>
   <span class="font11">different </span>
   <span class="font11">double; </span>
   <span class="font11">evaluated </span>
   <span class="font11">ibuprofen </span>
   <span class="font11">impact </span>
   <span class="font11">medical </span>
   <span class="font11">pharmacological </span>
   <span class="font11">reported </span>
   <span class="font11">school </span>
   <span class="font11">./j.-..hed.x </span>
   <span class="font11">./j.-..tb.x </span>
   <span class="font11">Ibuprofen </span>
   <span class="font11">Management </span>
   <span class="font11">Med </span>
   <span class="font11">Non-pharmacological </span>
   <span class="font11">Pediatrics </span>
   <span class="font11">Powers </span>
   <span class="font11">Wöber-Bingöl </span>
   <span class="font11">[], </span>
   <span class="font11">active </span>
   <span class="font11">adolescents. </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">early </span>
   <span class="font11">family </span>
   <span class="font11">frequency </span>
   <span class="font11">frequency) </span>
   <span class="font11">frequent </span>
   <span class="font11">include </span>
   <span class="font11">life </span>
   <span class="font11">limited </span>
   <span class="font11">migraine. </span>
   <span class="font11">positive </span>
   <span class="font11">rate </span>
   <span class="font11">research </span>
   <span class="font11">results </span>
   <span class="font11">review </span>
   <span class="font11">severity </span>
   <span class="font11">showing </span>
   <span class="font11">sodium </span>
   <span class="font11">solid; </span>
   <span class="font11">spray </span>
   <span class="font11">supporting </span>
   <span class="font11">used </span>
   <span class="font11">years </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11">Age </span>
   <span class="font11">Battistella </span>
   <span class="font11">Clonidine </span>
   <span class="font11">Evers </span>
   <span class="font11">Evidence </span>
   <span class="font11">Forsythe </span>
   <span class="font11">Galli </span>
   <span class="font11">Hoppu </span>
   <span class="font11">Migraine </span>
   <span class="font11">Pharmacological </span>
   <span class="font11">References </span>
   <span class="font11">Sills </span>
   <span class="font11">Suppl. </span>
   <span class="font11">Table </span>
   <span class="font11">Treatment </span>
   <span class="font11">Visser </span>
   <span class="font11">Wöber </span>
   <span class="font11">Zolmitriptan </span>
   <span class="font11">according </span>
   <span class="font11">available </span>
   <span class="font11">bold </span>
   <span class="font11">carried </span>
   <span class="font11">characteristics </span>
   <span class="font11">child </span>
   <span class="font11">children, </span>
   <span class="font11">children. </span>
   <span class="font11">children: </span>
   <span class="font11">clinically </span>
   <span class="font11">controlled, </span>
   <span class="font11">courier; </span>
   <span class="font11">crossover </span>
   <span class="font11">effectiveness </span>
   <span class="font11">em; </span>
   <span class="font11">emergency </span>
   <span class="font11">episodic </span>
   <span class="font11">findings </span>
   <span class="font11">increased </span>
   <span class="font11">levels </span>
   <span class="font11">lifestyle </span>
   <span class="font11">migraine, </span>
   <span class="font11">onset </span>
   <span class="font11">open </span>
   <span class="font11">overuse </span>
   <span class="font11">oxygen </span>
   <span class="font11">possible </span>
   <span class="font11">prevention </span>
   <span class="font11">psychiatric </span>
   <span class="font11">pt;} </span>
   <span class="font11">reduction </span>
   <span class="font11">regarding </span>
   <span class="font11">relaxation </span>
   <span class="font11">reviewed </span>
   <span class="font11">safety </span>
   <span class="font11">taken </span>
   <span class="font11">time </span>
   <span class="font11">training, </span>
   <span class="font11">vs. </span>
  </p>
 </body>
</html>
